• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchXilio Therapeutics
    Picture of Xilio Therapeutics logo

    XLO — Xilio Therapeutics News Story

    $7.570.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapTurnaround
    • Market Cap
      $49.81m
    • Enterprise Value
      -$86.23m
    • Revenue
      $43.77m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • XLO Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    XLO Dividends
    All News

    NASDAQ RESUMED AT 09:00 AM

    Picture of Xilio Therapeutics logoXilio Therapeutics
    16/03/2026 13:00
    NASDAQ RESUMED  XLO.O  AT 09:00 AM
    

    Recent news on Xilio Therapeutics

    See all news
    • Xilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

      12/08/2026 14:32
    • Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview

      12/08/2026 13:51
    • Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates

      12/08/2026 12:34
    • U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline

      23/03/2026 17:51
    • U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla

      23/03/2026 15:58

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.